Study design and participants
immunodeficiency disorder, gastrointestinal problems, anemia, asthma, rupture, allergies, diabetes
IMMUNODEFICIENCY DISORDER, POSTPARTUM HEMORRHAGE, ANEMIA, ASTHMA, CONNECTIVE TISSUE DISORDER, ALLERGIES, DISEASES, UTERUS, DIABETES
This triple-blind randomized clinical trial was conducted on 74 women delivered in Alzahra Hospital, Tabriz. The inclusion criteria were primiparous women with mediolateral episiotomy, singleton delivery, body mass index less than 30, membrane rupture ≤ 18 h, not habitual use of probiotic products, having no gastrointestinal problems, having no history of asthma and allergies to certain substances, episiotomy site length ≤ 5 cm, non-vegetarian diet, and having no history of diseases impairing wound healing, such as immunodeficiency disorder, connective tissue disorder, diabetes, and anemia. The exclusion criteria were curettage of the uterus due to postpartum hemorrhage, and other indications for antibiotic use in postpartum.